GDNF partially protects grafted fetal dopaminergic neurons against 6-hydroxydopamine neurotoxicity

David M. Yurek, Anita Fletcher-Turner

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Rats were given unilateral 6-hydroxydopamine (6-OHDA) lesions and subsequently received transplants of fetal ventral mesencephalic tissue into the denervated striatum. Four weeks later transplanted animals were tested for graft-mediated reduction of amphetamine-induced rotational behavior. Subsequently, transplanted animals received an intrastriatal injection of either GDNF (10 μg) or citrate buffer into a site lateral to the transplant, and then 6 h later received an injection of either 4.0 μg of 6-OHDA, 8.0 μg of 6-OHDA, or vehicle using the same stereotaxic coordinates that were used for the GDNF/citrate buffer injection. Animals were re-tested for amphetamine-induced rotational behavior 2 weeks later. Histological analysis revealed a significant reduction in the number of cell bodies immunostained for tyrosine hydroxylase (TH+) within the transplant for those animals pretreated with an intrastriatal injection of citrate buffer and subsequently given either dose of 6-OHDA. Transplanted animals pretreated with GDNF and subsequently administered 8.0 μg of 6-OHDA showed a significant reduction of TH+ neurons within the transplant compared to controls, however TH+ cell counts for this group remained significantly higher than the TH+ cell counts for the group of animals receiving the same dose of 6-OHDA but pretreated with citrate buffer. GDNF pretreatment completely protected TH+ cell bodies against 4.0 μg of 6-OHDA. Rotational scores indicated that GDNF provided only partial protection against 6-OHDA neurotoxicity in terms of transplant function. For both groups of transplanted animals receiving GDNF pretreatment and 6-OHDA injections, amphetamine-induced rotational scores dropped below the scores for animals pretreated with citrate buffer but remained significantly higher than the scores for transplanted animals that were not injected with 6-OHDA. Both histological and behavioral measures indicate GDNF partially protects integrated transplants against neurotoxic insult. Copyright (C) 1999 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)21-27
Number of pages7
JournalBrain Research
Volume845
Issue number1
DOIs
StatePublished - Oct 16 1999

Bibliographical note

Funding Information:
This research was supported by NS35890 and the generous gift of GDNF from Amgen.

Funding

This research was supported by NS35890 and the generous gift of GDNF from Amgen.

FundersFunder number
National Institute of Neurological Disorders and StrokeR01NS035890

    Keywords

    • Glial cell line-derived neurotrophic factor
    • Neural transplantation
    • Neuroprotection
    • Neurotrophic factor
    • Parkinson's disease

    ASJC Scopus subject areas

    • General Neuroscience
    • Molecular Biology
    • Clinical Neurology
    • Developmental Biology

    Fingerprint

    Dive into the research topics of 'GDNF partially protects grafted fetal dopaminergic neurons against 6-hydroxydopamine neurotoxicity'. Together they form a unique fingerprint.

    Cite this